hcpcs_code stringlengths 5 5 | hcpcs_description stringlengths 10 256 | n_providers int64 1 498k | total_services int64 408k 102M | total_medicare_payment int64 11.8k 8.43B | avg_submitted_charge int64 0 9.01k |
|---|---|---|---|---|---|
99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 498,045 | 102,377,857 | 8,429,417,260 | 275 |
A0425 | Ground mileage, per statute mile | 8,929 | 98,427,741 | 741,833,528 | 26 |
Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 11,573 | 95,202,153 | 9,678,886 | 2 |
J1010 | Injection, methylprednisolone acetate, 1 mg | 16,352 | 74,842,826 | 7,475,472 | 1 |
J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 187 | 73,288,310 | 37,283,782 | 1 |
99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 457,569 | 67,927,936 | 3,967,726,634 | 188 |
97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | 83,101 | 63,068,530 | 1,105,910,021 | 69 |
J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 958 | 61,165,045 | 220,117,291 | 14 |
A9575 | Injection, gadoterate meglumine, 0.1 ml | 3,298 | 53,453,861 | 5,063,156 | 1 |
J2777 | Injection, faricimab-svoa, 0.1 mg | 2,436 | 53,010,858 | 1,448,279,182 | 66 |
P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 280 | 49,474,872 | 53,268,273 | 2 |
J0897 | Injection, denosumab, 1 mg | 9,797 | 48,156,716 | 978,864,123 | 52 |
J0585 | Injection, onabotulinumtoxina, 1 unit | 3,723 | 46,383,230 | 225,551,859 | 14 |
97530 | Therapy procedure using functional activities | 70,092 | 43,562,919 | 1,063,442,995 | 75 |
36415 | Insertion of needle into vein for collection of blood sample | 85,982 | 39,989,147 | 339,504,704 | 22 |
J1439 | Injection, ferric carboxymaltose, 1 mg | 1,032 | 38,342,118 | 33,249,750 | 4 |
J3262 | Injection, tocilizumab, 1 mg | 722 | 35,790,556 | 166,745,517 | 11 |
99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 176,156 | 33,827,454 | 2,035,111,446 | 203 |
97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | 67,834 | 33,792,592 | 706,760,086 | 73 |
J0174 | Injection, lecanemab-irmb, 1 mg | 254 | 31,382,754 | 32,561,568 | 4 |
J3111 | Injection, romosozumab-aqqg, 1 mg | 1,339 | 28,416,634 | 241,453,680 | 22 |
97140 | Therapy procedure using manual technique, each 15 minutes | 67,054 | 28,359,909 | 450,466,794 | 68 |
J9271 | Injection, pembrolizumab, 1 mg | 1,922 | 28,218,856 | 1,242,513,566 | 137 |
J0878 | Injection, daptomycin, 1 mg | 193 | 27,807,315 | 1,170,365 | 1 |
80053 | Blood test, comprehensive group of blood chemicals | 26,072 | 27,147,672 | 280,436,313 | 61 |
Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 977 | 26,842,035 | 7,312,035 | 4 |
85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 32,034 | 26,108,717 | 198,275,222 | 37 |
G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 138,770 | 24,627,539 | 295,852,091 | 43 |
J1071 | Injection, testosterone cypionate, 1 mg | 678 | 23,689,546 | 411,462 | 0 |
99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 131,573 | 22,309,090 | 2,041,112,455 | 326 |
A9585 | Injection, gadobutrol, 0.1 ml | 3,135 | 20,730,418 | 5,072,987 | 3 |
J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 1,179 | 20,179,038 | 46,586,077 | 15 |
J1602 | Injection, golimumab, 1 mg, for intravenous use | 1,076 | 19,861,793 | 178,627,979 | 45 |
17003 | Destruction of precancer skin growth, 2-14 growths | 20,340 | 19,708,714 | 90,085,531 | 22 |
88305 | Pathology examination of tissue using a microscope, intermediate complexity | 14,573 | 18,351,551 | 707,769,609 | 186 |
80061 | Blood test, lipids (cholesterol and triglycerides) | 21,197 | 17,285,913 | 226,371,607 | 96 |
J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 38,760 | 17,037,070 | 12,364,995 | 10 |
J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 23,362 | 15,447,593 | 1,325,336 | 5 |
93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 51,118 | 15,348,910 | 92,789,959 | 45 |
99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | 30,091 | 14,712,800 | 1,101,657,091 | 211 |
83036 | Hemoglobin a1c level | 46,434 | 14,393,695 | 136,609,298 | 58 |
84443 | Blood test, thyroid stimulating hormone (tsh) | 19,436 | 13,847,047 | 227,681,029 | 96 |
J7192 | Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified | 4 | 13,603,433 | 15,340,522 | 3 |
J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 1,247 | 13,105,162 | 440,285,869 | 91 |
87798 | Detection test by nucleic acid for organism, amplified probe technique | 1,416 | 12,712,408 | 436,743,071 | 63 |
71045 | X-ray of chest, 1 view | 25,223 | 12,632,094 | 83,043,962 | 52 |
J1306 | Injection, inclisiran, 1 mg | 735 | 12,438,597 | 117,884,330 | 30 |
98941 | Chiropractic manipulative treatment, 3-4 spinal regions | 26,597 | 12,437,615 | 335,536,649 | 61 |
J1453 | Injection, fosaprepitant, 1 mg | 1,323 | 11,841,214 | 1,313,476 | 4 |
99215 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 153,625 | 11,827,816 | 1,424,342,188 | 407 |
99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more | 26,213 | 11,622,162 | 618,183,045 | 154 |
99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 232,660 | 11,508,274 | 1,277,271,515 | 410 |
G0008 | Administration of influenza virus vaccine | 112,062 | 11,327,225 | 329,061,888 | 40 |
G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 110,126 | 10,108,463 | 1,192,324,330 | 278 |
93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 68,409 | 9,777,098 | 100,048,209 | 69 |
J1756 | Injection, iron sucrose, 1 mg | 677 | 9,655,603 | 1,646,790 | 2 |
99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 140,980 | 9,607,216 | 1,255,751,512 | 568 |
92014 | Established patient complete exam of visual system | 35,261 | 9,164,899 | 760,787,596 | 227 |
99285 | Emergency department visit with high level of medical decision making | 64,318 | 8,984,062 | 1,175,277,457 | 1,235 |
J3380 | Injection, vedolizumab, intravenous, 1 mg | 746 | 8,328,838 | 143,429,242 | 53 |
90480 | Admn sarscov2 vacc 1 dose | 54,794 | 8,303,881 | 315,441,742 | 50 |
J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 765 | 8,288,764 | 323,003,588 | 131 |
92134 | Imaging of retina | 27,541 | 8,111,308 | 234,809,890 | 124 |
J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 815 | 7,885,670 | 10,319,158 | 3 |
J9299 | Injection, nivolumab, 1 mg | 441 | 7,881,796 | 191,282,270 | 78 |
J0185 | Injection, aprepitant, 1 mg | 826 | 7,828,538 | 10,450,936 | 7 |
99203 | New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | 155,883 | 7,685,964 | 538,312,723 | 266 |
95004 | Test for allergy using allergenic extract | 3,637 | 7,654,997 | 21,500,345 | 13 |
J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 444 | 7,575,407 | 3,060,616 | 5 |
J9263 | Injection, oxaliplatin, 0.5 mg | 523 | 7,035,422 | 390,695 | 16 |
J9267 | Injection, paclitaxel, 1 mg | 917 | 7,030,641 | 561,620 | 4 |
93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 24,796 | 6,743,227 | 569,011,003 | 475 |
99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 18,757 | 6,682,760 | 303,492,327 | 113 |
66984 | Removal of cataract with insertion of prosthetic lens | 15,527 | 6,680,450 | 1,607,135,368 | 1,272 |
C9290 | Injection, bupivacaine liposome, 1 mg | 503 | 6,609,247 | 7,324,780 | 5 |
71046 | X-ray of chest, 2 views | 47,619 | 6,490,270 | 74,912,200 | 71 |
90662 | Influenza vaccine split virus, preservative free | 70,747 | 6,486,542 | 524,368,452 | 97 |
82306 | Vitamin d-3 level | 12,597 | 6,376,292 | 184,675,203 | 185 |
81001 | Manual urinalysis test with examination using microscope, automated | 12,761 | 6,288,838 | 19,520,525 | 32 |
17000 | Destruction of precancer skin growth, 1 growth | 22,412 | 6,217,347 | 220,007,658 | 155 |
77067 | Screening mammography | 14,871 | 6,023,902 | 392,144,937 | 248 |
99212 | Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more | 90,889 | 5,819,455 | 216,133,383 | 116 |
77063 | Screening 3d breast mammography | 14,180 | 5,781,923 | 197,073,879 | 138 |
96372 | Injection of drug or substance under skin or into muscle | 56,574 | 5,731,447 | 56,375,668 | 55 |
Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 228 | 5,691,064 | 1,233,659 | 2 |
J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,377 | 5,576,857 | 137,038,110 | 134 |
82570 | Creatinine level to test for kidney function or muscle injury | 13,102 | 5,488,379 | 27,777,862 | 46 |
99291 | Critical care, first 30-74 minutes | 73,484 | 5,457,118 | 897,202,650 | 1,054 |
84439 | Thyroxine (thyroid chemical), free | 10,641 | 5,399,478 | 47,651,980 | 88 |
81003 | Automated urinalysis test | 53,174 | 5,381,053 | 11,779,961 | 15 |
99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 115,957 | 5,366,122 | 528,263,761 | 364 |
11721 | Removal of fingernails or toenails, 6 or more nails | 12,574 | 5,331,089 | 166,198,891 | 85 |
J3145 | Injection, testosterone undecanoate, 1 mg | 92 | 5,322,778 | 7,859,448 | 4 |
95165 | Professional service for preparation and provision of 1 or more antigens | 3,124 | 5,235,817 | 54,576,130 | 29 |
99239 | Hospital discharge day management, more than 30 minutes | 64,431 | 5,221,363 | 454,832,692 | 354 |
80048 | Blood test, basic group of blood chemicals (calcium, total) | 13,827 | 5,063,616 | 41,864,079 | 48 |
G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 15,542 | 5,054,625 | 34,247,707 | 39 |
70450 | Ct scan head or brain without contrast | 21,081 | 4,896,874 | 147,847,888 | 245 |
82607 | Cyanocobalamin (vitamin b-12) level | 11,361 | 4,643,777 | 68,523,819 | 88 |
20610 | Aspiration and/or injection of fluid from large joint | 39,307 | 4,517,739 | 217,527,515 | 291 |
End of preview. Expand in Data Studio
National Medicare Part B Procedure-Volume Summary
Top 500 Medicare procedures (HCPCS) by volume: providers, services, payment, avg charge. Aggregated from the CMS Part B PUF. Per-NPI detail: https://caretrace.io
Free CC0 summary derived from public US-government data. Maintained by Healthparse.
- Downloads last month
- 30